Quantcast

Latest Amines Stories

2014-07-02 23:06:10

BCC Research (http://www.bccresearch.com) is pleased to announce the BCC Research Strattera® Forecast, a strategic investment product designed to provide market data for the pharmaceutical drug, Strattera®, a treatment for Attention Deficit Hyperactivity Disorder (ADHD) distributed by Eli Lilly and Company. Strattera® will lose its branded patent protection in late 2016 going into 2017, opening the market to distribution of generic treatments by competing companies....

2014-07-02 08:23:13

DUBLIN, July 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/4cfzmn/glyphosate_market) has announced the addition of the "Glyphosate Market for Genetically Modified and Conventional Crops - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Growing demand from key end-use applications in glyphosate tolerant GM crops and conventional crops is...

2014-06-30 08:30:01

LUGANO, Switzerland, June 30, 2014 /PRNewswire/ -- Exclusive distribution and licensing agreement signed for the commercialization of Helsinn's compound currently in development for the treatment of cancer anorexia-cachexia syndrome in non-small cell lung cancer (NSCLC) patients Helsinn Group, the company focused on building quality cancer care, today announces that rights to anamorelin, its innovative ghrelin receptor agonist, have been granted in Turkey to GEN Ilac....

2014-06-26 23:12:28

AffordRx offers discounts of 10-75% on name-brand fibromyalgia treatments. Houston, TX (PRWEB) June 26, 2014 Recent surveys show that about 2% of Americans currently suffer from fibromyalgia. Most of these are women, with about 20% of new diagnoses being men or children. Fibromyalgia can present itself with many different symptoms, including sensitivity to light, odors, and noise, or more acute symptoms like facial pain and TMJ (lockjaw). On average, patients dealing with fibromyalgia...

2014-06-26 08:27:08

Top-line results anticipated by end-of-year RALEIGH, N.C., June 26, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed enrollment of all patients required for its initial Phase 3 study of Clonidine Topical Gel for the treatment of painful diabetic neuropathy (PDN). http://photos.prnewswire.com/prnvar/20110217/CL49801LOGO The Phase 3 trial is a multicenter, randomized, double-blind, placebo-controlled study to determine the...

2014-06-20 23:03:17

Las Vegas Rapid Detox Medical Clinic is pleased to announce that they reached the milestone of performing 500 successful rapid opiate detox procedures without any complications. Las Vegas, NV (PRWEB) June 20, 2014 Opiate detox can be an extremely painful thing to go thorugh. However, with Las Vegas Rapid Detox’s groundbreaking 8 hour rapid detox procedure, patients can detox from opiates in only eight hours without suffering any signs of withdrawal. Las Vegas Rapid Detox’s procedure...

New Tool Predicts The Painful 'COST' Of Cancer
2014-06-20 12:51:43

Brett Smith for redOrbit.com - Your Universe Online While cancer treatment is well-known for the physical and emotional stress it puts on a patient, a new study has revealed new details about the financial pain that treatment can inflict on a person. Published in the journal Cancer, the new study resulted in the development of an 11-question tool called the COmprehensive Score for financial Toxicity (COST) that can accurately measure a patient's risk for, and capacity to withstand,...

Prescription Pain Killer Deaths Outnumber Heroin, Cocaine Overdoses
2014-06-18 07:35:39

Rebekah Eliason for redOrbit.com – Your Universe Online Reports from a new study at McGill University indicate that there are a greater number of deaths from commonly prescribed painkillers than from heroin and cocaine overdose combined. This study is the first of its kind and highlights a huge public health issue. Death from prescribed painkillers has dramatically increased in recent years with 16,000 US deaths in 2010. In per capita opioid consumption, the United States and Canada...

2014-06-17 13:13:51

American Society of Anesthesiologists Fast-acting ketamine by-product may be future therapy for Alzheimer's, Parkinson's There is new hope for people suffering from depression. Researchers have identified a compound, hydroxynorketamine (HNK), that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study in the July issue of Anesthesiology, the official medical journal of...

2014-06-17 08:30:31

Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual functioning from a head-to-head study of Brintellix(®) (vortioxetine) vs. escitalopram in patients with well treated major depressive disorder (MDD) experiencing treatment-emergent sexual...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related